KLK3 and Familial prostate cancer: Additionally, overestimation of sensitivity and underestimation of specificity of the test is driven by the fact that men will not be biopsied at normal ranges of PSA unless having an abnormal digital rectal examination, making its performance assessment inaccurate.20 Also, since PSA often detects low-risk disease, performance status should be evaluated for clinically significant prostate cancer.